In an RCT with 47 patients with PD, the use of nabilone, acting as a partial agonist on both CB1 and CB2 receptors in humans, mimicking AEA, could reduce sleep and anxiety (Peball et al., 2020). The gene discussed is CNR1; the disease is Parkinson disease.